Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Kiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 851-861
Closed Access | Times Cited: 1270

Showing 76-100 of 1270 citing articles:

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Stefano Ciardullo, Michela Vergani, Gianluca Perseghin
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5597-5597
Open Access | Times Cited: 33
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Young‐Sun Lee, Ekihiro Seki
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 16, Iss. 3, pp. 355-367
Open Access | Times Cited: 32
Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings
Chul‐min Lee, Eileen L. Yoon, Mimi Kim, et al.
Hepatology (2023) Vol. 79, Iss. 6, pp. 1393-1400
Closed Access | Times Cited: 32
Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling
Wei Peng, Cheng-Xun He, Ruolan Li, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116848-116848
Closed Access | Times Cited: 30
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
Cristina Bică, Roxana Adriana Stoica, Teodor Salmen, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1136-1136
Open Access | Times Cited: 28
Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018
Zhilan Xie, Ruxianguli Aimuzi, Mingyu Si, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 27
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
Yu Zhu, Yang Hu, Yaozong Zhang, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 26
Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution
Arianna Dolce, Sara Della Torre
Nutrients (2023) Vol. 15, Iss. 10, pp. 2335-2335
Open Access | Times Cited: 26
MAIT cells and the microbiome
Maisha Jabeen, Timothy S.C. Hinks
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials
Yunpeng Gu, Lei Sun, Wei Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis
Sachin Amonker, Aryo Houshmand, Alexander Hinkson, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 25
Neuregulin 4 as a novel adipokine in energy metabolism
Yuanbin Liu, Mingkai Chen
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 24
Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
Feiwei Cao, Qinchao Ding, Hui Zhuge, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 23
Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake
Kexin Nie, Yang Gao, Shen Chen, et al.
Phytomedicine (2023) Vol. 111, pp. 154661-154661
Open Access | Times Cited: 23
Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis
Babita Shashni, Yuya Tajika, Yutaka Ikeda, et al.
Biomaterials (2023) Vol. 295, pp. 122047-122047
Closed Access | Times Cited: 23
Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Alexey A. Tinkov, Michael Aschner, Abel Santamarı́a, et al.
Environmental Research (2023) Vol. 238, pp. 117134-117134
Closed Access | Times Cited: 23
Dietary and lifestyle oxidative balance scores are independently and jointly associated with nonalcoholic fatty liver disease: a 20 years nationally representative cross-sectional study
Yuanbin Liu, Mingkai Chen
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 23
Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
S Kamata, Akihiro Honda, Ryo Ishikawa, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1523-1523
Open Access | Times Cited: 22
Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
Jiaming Lai, Ling Luo, Ting Zhou, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 22
Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Xin Su, Shiyun Chen, Jiazi Liu, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Closed Access | Times Cited: 22
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease
Guillaume Hénin, Audrey Loumaye, Isabelle Leclercq, et al.
JHEP Reports (2023) Vol. 6, Iss. 2, pp. 100963-100963
Open Access | Times Cited: 22
Nutrition Assessment and Management in Celiac Disease
María Inés Pinto-Sánchez, Jedid-Jah Blom, Peter R. Gibson, et al.
Gastroenterology (2024)
Closed Access | Times Cited: 14
The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis
Karlo Mladenić, Maja Lenartić, Sonja Marinović, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 4
Open Access | Times Cited: 13

Scroll to top